-
-
-
-
Manufacturing
-
BIOLOGICS
Ofatumumab
FORM：
Injection
STRENGTH：
20 mg/0.4 mL (PFS, Autoinjector)
Vedolizumab
FORM：
For Injection
STRENGTH：
300 mg (Vial)
Benralizumab
FORM：
Injection
STRENGTH：
30 mg/mL (PFS, Autoinjector)
Romosozumab
FORM：
Injection
STRENGTH：
105 mg/1.17 mL (PFS, Autoinjector)
Abatacept
FORM：
Injection
STRENGTH：
250 mg (Vial), 50 mg/0.4 mL (PFS), 87.5 mg/0.7 mL (PFS), 125 mg/1 mL (PFS), 125 mg/1 mL (Autoinjector)
Belimumab
FORM：
Injection
STRENGTH：
120 mg (Vial), 400 mg (Vial), 200 mg/mL (PFS, Autoinjector)
Ravulizumab
FORM：
Injection
STRENGTH：
300 mg/3 mL (Vial), 1,100 mg/11 mL (Vial)
Secukinumab
FORM：
Injection
STRENGTH：
150 mg/mL (Autoinjector)
Vedolizumab
FORM：
Injection
STRENGTH：
108 mg/0.68 mL (PFS), 300 mg (Vial)
Donanemab
FORM：
Injection
STRENGTH：
350 mg/20 mL (Vial)
Pertuzumab/Trastuzumab/Hyaluronidase
FORM：
Injection
STRENGTH：
600 mg, 600 mg, 20,000 Units/10 mL; 1,200 mg, 600 mg, 30,000 Units/15 mL (Vial)
Trastuzumab Deruxtecan
FORM：
For Injection
STRENGTH：
100 mg (Vial)
Icodec Insulin/Semaglutide
FORM：
Injection
STRENGTH：
0.43 mL, 1 mL, 1.5 mL (Pre-filled Pen)
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail：export@qilu-pharma.com, FDF@qilu-pharma.com